COMBINATION OF LENVATINIB AND PEMBROLISUMAB IN THE TREATMENT OF ADVANCED ENDOMETRIAL CANCER: A CASE REPORT
Background. Endometrial cancer is the most common malignancy of the female reproductive system. Patients with metastatic endometrial cancer have the overall 5-year survival rate of less than 20 %. The efficacy of treatment of advanced endometrial cancer remains low; therefore, the search for novel a...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Tomsk National Research Medical Center of the Russian Academy of Sciences
2021-03-01
|
| Series: | Sibirskij Onkologičeskij Žurnal |
| Subjects: | |
| Online Access: | https://www.siboncoj.ru/jour/article/view/1705 |